Summary & Overview
CPT 80307: Presumptive Instrumented Drug Screen
Headline: New Overview — CPT code 80307 for Instrumented Presumptive Drug Screening
Lead: CPT code 80307 designates a laboratory-performed presumptive drug test using instrumented chemistry analyzers to screen for multiple drug classes on a single date. The code captures a widely used screening method that supports clinical decision-making, substance use monitoring, and workplace or forensic testing pathways.
What the code represents and why it matters: CPT code 80307 identifies an automated, instrument-based toxicology screen that produces rapid qualitative results across drug classes. As presumptive testing is often the initial step before confirmatory assays, this code is central to workflows in emergency care, occupational health, behavioral health, and inpatient settings. Nationally, standardized coding of these screens affects billing consistency, utilization tracking, and laboratory service reporting.
Key payers included: This summary covers payer applicability for Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
What readers will learn: The publication presents benchmarks for utilization and reimbursement patterns, outlines common clinical contexts where 80307 is used, and summarizes relevant policy considerations affecting laboratory toxicology screening. It also highlights operational implications for laboratories and ordering clinicians, and notes where input data are not available. The focus is national in scope and designed for billing managers, laboratory directors, and policy analysts seeking a concise reference on CPT code 80307.
Billing Code Overview
CPT code 80307 describes a presumptive drug test performed by a laboratory analyst using instrumented chemistry analyzers to screen for any number of drug classes on a single date. This service is a laboratory-based toxicology screening that produces qualitative results indicating the presence or absence of target drug classes.
Service type: Laboratory toxicology screen (instrumented chemistry analyzer service)
Typical site of service: Clinical laboratory or hospital laboratory; testing may be ordered by outpatient clinics, emergency departments, inpatient services, or other clinical settings and performed in a certified laboratory.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an emergency department or outpatient clinic with altered mental status, suspected drug ingestion, possible overdose, or as part of workplace or pre-procedural screening. A clinician orders a presumptive urine or serum drug screen performed by the laboratory using instrumented chemistry analyzers to rapidly screen for multiple drug classes on a single date. The workflow: clinician documents indication and collects a specimen, the specimen is accessioned in the lab, an automated immunoassay or chemistry analyzer panel is run under the supervision of a laboratory analyst, results are verified and routed to the ordering clinician. Positive or unexpected presumptive results frequently trigger confirmatory testing (e.g., gas chromatography-mass spectrometry) and clinician notification for patient management decisions such as naloxone administration, observation, or consultation with toxicology.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation component if the lab distinguishes technical vs professional components. |
90 | Reference laboratory |